Characteristics | Biopsy-induced bleeding | |
---|---|---|
No (n = 391) | Yes (n = 224) | |
Age (y), median (range) | 65.00 (32–85) | 65.50 (36–82) |
Sex, n (%) | ||
Female | 94 (24.04) | 41 (18.30) |
Man | 297 (75.96) | 183 (81.70) |
Smoking, n (%) | ||
Never | 158 (40.41) | 68 (30.36) |
Former | 56 (14.32) | 44 (19.64) |
Current | 177 (45.27) | 112 (50.00) |
SBP (mmHg) | 132.34 ± 0.98 | 130.01 ± 1.37 |
DBP (mmHg) | 77.95 ± 0.58 | 78.60 ± 0.82 |
Location of lesion, n (%) | ||
Peripheral bronchi | 362 (92.58) | 175 (78.12) |
Central airway | 29 (7.42) | 49 (21.88) |
Stage, n (%) | ||
Early | 237 (60.61) | 98 (44.95) |
Advanced | 154 (39.39) | 120 (55.05) |
Histological types, n (%) | ||
Adenocarcinoma | 130 (33.25) | 36 (16.07) |
Squamous cell carcinoma | 175 (44.76) | 134 (59.82) |
SCLC | 67 (17.14) | 41 (18.30) |
Others | 19 (4.86) | 13 (5.80) |
COPD, n (%) | ||
No | 365 (93.35) | 208 (92.86) |
Yes | 26 (6.65) | 16 (7.14) |
Hypertension, n (%) | ||
No | 297 (75.96) | 166 (74.11) |
Yes | 94 (24.04) | 58 (25.89) |
Diabetes, n (%) | ||
No | 370 (94.63) | 214 (95.54) |
Yes | 21 (5.37) | 10 (4.46) |
CHD, n (%) | ||
No | 379 (96.93) | 216 (96.43) |
Yes | 12 (3.07) | 8 (3.57) |
Triglyceride (mmol/L) | 1.24 ± 0.03 | 1.15 ± 0.05 |
TC (mmol/L) | 4.19 ± 0.06 | 4.10 ± 0.06 |
HDLC (mmol/L) | 1.18 ± 0.02 | 1.12 ± 0.02 |
LDLC (mmol/L) | 2.84 ± 0.04 | 2.77 ± 0.05 |
Apo E (mg/dL) | 3.90 ± 0.07 | 3.65 ± 0.10 |
Apo B (g/L) | 1.02 ± 0.02 | 0.99 ± 0.02 |
Homocysteine (μmol/L) | 15.05 ± 0.43 | 20.48 ± 5.23 |
WBC (× 109/L) | 7.31 ± 0.16 | 7.62 ± 0.22 |
Neutrophils (×109/L) | 5.23 ± 0.16 | 5.70 ± 0.22 |
Hemoglobin (g/L) | 127.66 ± 1.69 | 126.96 ± 1.71 |
platelets (× 109/L) | 229.10 ± 4.34 | 241.23 ± 6.63 |
CRP (mg/L) | 21.81 ± 1.73 | 29.81 ± 2.61 |
PT (S) | 16.04 ± 1.22 | 13.90 ± 0.74 |
APTT (S) | 38.83 ± 1.38 | 35.58 ± 1.15 |
ALT (IU/L) | 22.27 ± 0.91 | 21.48 ± 1.39 |
AST (IU/L) | 26.54 ± 0.73 | 26.52 ± 1.20 |